Hong Jiang

Company: Avotres

Job title: Founder & Chief Scientific Officer

Seminars:

Analyzing the Q/E CD8+ Treg Pathway to Unlock Effective Clinical Applications 9:30 am

Unravelling the unique mechanisms of the Q/E CD8+ Treg pathway Detailing preclinical studies in animals and non-clinical ex vivo studies in humans Analyzing safety and efficacy in newly completed phase I/II clinical trials in T1D Exploring platforms of drug production and precision assay systems production platforms to ensure precision assay systemsRead more

day: Focus Day